• Rhodamine B as a Fluorescent Probe for Pesticide Drift Analy

  2026-06-08

  Rhodamine B (Basic Violet 10) shines in environmental and cell biology workflows as a high-sensitivity fluorescent probe. This article breaks down its applied use in UAV pesticide drift studies, protocol optimization, and troubleshooting strategies that empower researchers to achieve reproducible and quantitative fluorescent results.

• Affinity-Purified Goat Anti-Rabbit IgG (H+L): Precision in I

  2026-06-08

  Unlock unmatched sensitivity in Western blot, ELISA, and IHC with the Affinity-Purified Goat Anti-Rabbit IgG (H+L), Horseradish Peroxidase Conjugated Secondary Antibody. This APExBIO reagent delivers robust signal amplification, exceptional specificity, and seamless workflow integration for complex immunoassays.

• Mapping Subcellular RNA-Binding Proteins via Functional Prox

  2026-06-07

  This study introduces APEX-PS, a method that unifies peroxidase-catalyzed proximity labeling with phase separation to map RNA-binding proteins (RBPs) in specific subcellular compartments. Application of APEX-PS revealed distinct RBP populations and identified SYNJ2BP as a mitochondrial mRNA anchor critical for stress recovery, offering new insight into spatially resolved protein function.

• HRP Goat Anti-Rabbit IgG (H+L) Antibody: Technical Workflow

  2026-06-06

  The HRP Goat Anti-Rabbit IgG (H+L) Antibody addresses the need for sensitive and specific detection of rabbit primary antibodies in immunoassays, including Western blot, ELISA, and IHC. It should not be used for diagnostic or clinical purposes and requires careful handling to maintain stability and performance.

• Dissecting Drug Responses in Cancer: Insights from In Vitro

  2026-06-05

  Schwartz's dissertation introduces a systematic approach to disentangle proliferative arrest and cell death in cancer drug response assays. By clarifying the differences between relative and fractional viability, the study offers more accurate tools for evaluating anti-cancer agents, informing both preclinical research design and interpretation.

• Ectomesenchymal Stem Cells Modulate Microglia After Brain He

  2026-06-05

  This study demonstrates that transplantation of ectomesenchymal stem cells (EMSCs) from nasal mucosa promotes microglial polarization toward an anti-inflammatory phenotype and increases IL-10 secretion after intracerebral hemorrhage (ICH) in mice. By inhibiting microglial NF-κB and MAPK signaling, EMSCs mitigate neuroinflammation and neuronal injury, suggesting a promising therapeutic avenue for hemorrhagic stroke recovery.

• Cy3 TSA Fluorescence System Kit: High-Sensitivity Detection

  2026-06-04

  The Cy3 TSA Fluorescence System Kit enables ultrasensitive signal amplification in immunohistochemistry and related assays. This TSA fluorescence kit leverages HRP-catalyzed tyramide deposition to detect low-abundance biomolecules with robust fluorescence microscopy detection.

• Trelagliptin Succinate Improves Insulin Signaling in Adipocy

  2026-06-04

  This study demonstrates that trelagliptin succinate enhances insulin sensitivity in adipocytes by activating the PI-3K/AKT/GLUT4 signaling pathway and modulating adipokine secretion. These findings clarify the molecular basis of trelagliptin’s anti-diabetic effects and offer experimental guidance for phosphorylation-focused metabolic research.

• SAR405: Precision Vps34 Inhibitor for Autophagy Research

  2026-06-03

  SAR405, a nanomolar-potency Vps34 inhibitor from APExBIO, empowers researchers to dissect autophagy inhibition and vesicle trafficking with unmatched specificity. This guide translates recent mechanistic insights and validated protocols into actionable workflows, troubleshooting tips, and advanced applications for cancer and lysosomal disease models.

• Doxorubicin Experimental Workflows in Cancer Cell Assays

  2026-06-03

  Doxorubicin (Adriamycin) is a cornerstone chemotherapeutic agent for solid tumors and hematologic malignancy research, renowned for its dual DNA intercalating and topoisomerase II inhibitory activity. This guide delivers actionable workflows, troubleshooting tips, and the latest innovations for maximizing reproducibility and data quality using APExBIO’s Doxorubicin.

• LGI1 Synaptic Translocation Regulates Glutamatergic Transmis

  2026-06-02

  Cuhadar et al. (2024) reveal that LGI1 is dynamically translocated to the presynaptic membrane in response to neuronal activity, where its surface abundance tightly regulates glutamate release. These findings clarify LGI1’s mechanistic role in synaptic modulation and provide a framework for understanding its involvement in epilepsy and related disorders.

• Thioguanine (6-Thioguanine): Nanodelivery Advances and Preci

  2026-06-02

  Explore the latest scientific advances in Thioguanine (6-thioguanine), including chitosan nanoparticle-mediated delivery and its implications for cancer research and inflammatory bowel disease treatment. This article offers unique, actionable insights absent from standard reviews.

• Chrysin Sensitizes RCC to Sunitinib via PI3K/Akt/GPX4 Ferrop

  2026-06-01

  This study reveals that chrysin, a natural flavonoid, enhances the sensitivity of renal cell carcinoma (RCC) cells to sunitinib by inducing ferroptosis through suppression of the PI3K/Akt/GPX4 pathway. The findings provide mechanistic insight and a potential therapeutic strategy to overcome sunitinib resistance in RCC.

• Applied Workflows with the 10 mM dNTP Mixture in Molecular B

  2026-06-01

  The 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture empowers researchers with consistent, high-fidelity results in PCR, qPCR, and DNA sequencing workflows. Its equimolar, pH-stabilized formulation from APExBIO removes preparation variability, streamlining advanced experimental applications and troubleshooting.

• Bufalin-CRISPR Nanomedicine Induces Pyroptosis in Colorectal

  2026-05-31

  The referenced study pioneers a calcium lactate nanoparticle system that co-delivers bufalin and CRISPR/Cas9 RNP, inducing pyroptosis and macrophage immunoreprogramming in colorectal cancer. This approach shows strong antitumor effects by targeting both tumor cells and the immunosuppressive microenvironment, offering a promising direction for overcoming immunotherapy resistance.

703 records 16/47 page Previous Next First page 上5页 1617181920 下5页 Last page